| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.25 | 6e-06 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | 0.14 | 4e-05 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | marinopyrrole A | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0002 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.2 | 0.0002 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0005 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |